VP

Vishnu Prasad Choorayi

Active Director Director DIN 09474788
DIN 09474788 First appointment Jan 2022 Primary industry Recycling & Waste Management
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Vishnu Prasad Choorayi

Data last updated:

Vishnu Prasad Choorayi is a Director at Rejuvenity Biotech Private Limited (since 2022). The company operates in Recycling & Waste Management.

DIN 09474788
Primary Designation Director
Industry Recycling & Waste Management
First Appointment 20 Jan 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rejuvenity Biotech Private Limited U37100KL2022PTC073540
Director20 Jan 20222022Active

Board colleagues of Vishnu Prasad Choorayi

NameDINCompanyDesignation
Akshay Mohan09243026Rejuvenity Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rejuvenity Biotech Private Limited
Premium access

Shareholding and investment profile for Vishnu Prasad Choorayi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vishnu Prasad Choorayi

Vishnu Prasad Choorayi currently holds 1 directorship: Rejuvenity Biotech Private Limited (Director, since 20 Jan 2022).

Vishnu Prasad Choorayi was first appointed on 20 Jan 2022 as Director at Rejuvenity Biotech Private Limited.

The current boards of Vishnu Prasad Choorayi's companies include Akshay Mohan (Rejuvenity Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available